For FY09, the Integrated Research Facility in the Division of Clinical Research has significantly increased the level of research facilitation that it provides. Primarily, this support has been directed to facilitating the biodefense and emerging infectious disease research of the Emerging Viral Pathogens section in the Division of Intramural Research. Project 1: Viral pathogenesis of orthopoxviruses and development of countermeasures against infection: Introduction and Objectives 1) Characterize monkeypox virus infection of nonhuman primates by the intravenous and intrabronchial route. 2) Determine if cowpox virus infection of nonhuman primates could serve as a BSL-2 model of orthopoxvirus infection. 3) Determine the efficacy of mitoxantrone against cowpox virus in vivo. Project 2: Viral pathogenesis of simian hemorrhagic fever virus: Introduction and Objectives 1) To characterize the pathogenesis of simian hemorrhagic fever virus in nonhuman primates. Project 3: Identification of cell-surface receptors of viral entry: 1) Identification of cell-surface receptors for NIAID Priority Pathogens. 2) Identification of the cell-surface receptor of simian hemorrhagic fever virus. 3) Characterization of the role of filoviral secreted glycoproteins in filovirus cell entry. Project 4: Develop methods for medical imaging of infectious disease: 1) Development of tracers for orthopox viruses and filoviruses.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2009
Total Cost
$34,269,307
Indirect Cost
City
State
Country
Zip Code
St Claire, Marisa C; Ragland, Dan R; Bollinger, Laura et al. (2017) Animal Models of Ebolavirus Infection. Comp Med 67:253-262
Bennett, Richard S; Huzella, Louis M; Jahrling, Peter B et al. (2017) Nonhuman Primate Models of Ebola Virus Disease. Curr Top Microbiol Immunol :
Honko, Anna N; Johnson, Joshua C; Marchand, Jonathan S et al. (2017) High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona. Sci Rep 7:5886
Nelson, Elizabeth A; Dyall, Julie; Hoenen, Thomas et al. (2017) The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. PLoS Negl Trop Dis 11:e0005540
Moncla, Louise H; Weiler, Andrea M; Barry, Gabrielle et al. (2017) Within-Host Evolution of Simian Arteriviruses in Crab-Eating Macaques. J Virol 91:
Cnops, Lieselotte; van Griensven, Johan; Honko, Anna N et al. (2016) Overlooking the importance of immunoassays - Authors' reply. Lancet Infect Dis 16:1110
Bohannon, J Kyle; Janosko, Krisztina; Holbrook, Michael R et al. (2016) Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology. J Vis Exp :
Byrum, Russell; Keith, Lauren; Bartos, Christopher et al. (2016) Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures. J Vis Exp :
Broce, Sean; Hensley, Lisa; Sato, Tomoharu et al. (2016) Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals. Biol Direct 11:25
Johnson, Reed F; Kurup, Drishya; Hagen, Katie R et al. (2016) An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models. J Infect Dis 214:S342-S354

Showing the most recent 10 out of 59 publications